Form 4: Albemarle Director Diarmuid O'Connell Boosts Stake with Annual Stock Compensation and Dividend Shares
Insider Transaction Report
Albemarle Corporation Director Diarmuid B. O'Connell reported the acquisition of 2,725 shares as annual stock compensation and an additional 37 shares from accrued dividends, increasing his direct beneficial ownership to 8,233 shares.
Summary
- Diarmuid B. O'Connell, a Director of Albemarle Corporation, acquired 2,725 shares of common stock on July 1, 2025.
- These shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation.
- The 2,725 shares are scheduled to vest on July 1, 2026.
- Additionally, O'Connell acquired 37 shares of common stock on July 1, 2025, which represent dividends accrued on shares from an award granted on July 1, 2024.
- These dividend shares vested in full on July 1, 2025, and were settled in common stock by Albemarle under the 2023 Directors Plan.
- Following these transactions, Diarmuid B. O'Connell's direct beneficial ownership of Albemarle common stock increased to 8,233 shares.
Sentiment
Score: 6
Explanation: The filing is neutral to slightly positive, reflecting routine director compensation and increased insider ownership, which generally aligns interests. It contains no negative news or unexpected events.
Positives
- Director O'Connell's increased stake aligns his interests further with shareholders.
- The issuance of shares as compensation and for dividends indicates a standard practice of director remuneration and dividend reinvestment.
Future Outlook
The filing indicates a future vesting event for director stock compensation on July 1, 2026, as part of the ongoing 2023 Directors Plan.
Management Comments
- Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the '2023 Directors Plan'). Shares to vest on July 1, 2026.
- Represents dividends accrued on shares underlying an award granted on July 1, 2024, that vested in full on July 1, 2025, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.
Industry Context
This Form 4 filing reflects a routine insider transaction related to director compensation, which is a common practice across publicly traded companies to align director interests with shareholders. It does not provide specific insights into broader industry trends for the chemical or lithium sectors, but rather details standard corporate governance and compensation mechanisms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Implementation | The 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation is the basis for the annual stock compensation and dividend settlement. | 2023 | This plan provides a structured framework for compensating non-employee directors with equity, aligning their interests with long-term shareholder value. |
| Power of Attorney Grant | Diarmuid B. O'Connell granted a Power of Attorney to specific individuals to handle his SEC filings (Forms 3, 4, 5, 13D, 13G, 144) and EDGAR account administration. | 06/17/2025 | This streamlines the compliance process for the director's reporting obligations under Section 13 and Section 16 of the Exchange Act, ensuring timely and accurate filings. |
Related Party Transactions
- The acquisition of 2,725 shares as annual non-employee director stock compensation from Albemarle Corporation.
- The acquisition of 37 shares representing dividends accrued on a prior award, settled in common stock by Albemarle Corporation.
Stakeholder Impact
- Shareholders: Increased insider ownership by a director can be viewed positively as it aligns management interests with shareholder value.
- Employees: No direct impact mentioned.
- Customers/Suppliers/Creditors: No direct impact mentioned.
Next Steps
- Vesting of 2,725 shares of common stock on July 1, 2026.
Key Dates
| Date | Description |
|---|---|
| 2023 | Year of the Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation. |
| 07/01/2024 | Date of the original award grant on which dividends accrued. |
| 06/17/2025 | Date the Power of Attorney was executed by Diarmuid B. O'Connell. |
| 07/01/2025 | Date of the earliest transaction, including the acquisition of 2,725 shares as annual compensation and 37 dividend shares, and the vesting of dividend shares. |
| 07/03/2025 | Date the Form 4 was signed by the Attorney-in-Fact. |
| 07/01/2026 | Vesting date for the 2,725 shares of annual non-employee director stock compensation. |
Recommendation
holdKeywords
Albemarle Corporation, ALB, Form 4, SEC filing, Director compensation, Stock award, Equity compensation, Insider transaction, Common stock, Dividend reinvestment, Corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.